http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8899210

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Controlled Clinical Trial|Journal Article
endingPage 1173
issn 1532-1827
0007-0920
issueIdentifier 9
pageRange 1167-1173
publicationName British Journal of Cancer
startingPage 1167
bibliographicCitation Klatte T, Ittenson A, Röhl F, Ecke M, Allhoff EP, Böhm M. Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial. British Journal of Cancer. 2006 Oct 10;95(9):1167–73. doi: 10.1038/sj.bjc.6603391.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_67412adbf091a2b0d1da9871157cc890
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c77df438dd6cb3d4fe4be7ac78259dd1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1d95acf2e707e18ab65d4a4409fb803
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ebc9924da5a5a91367ec8bd2c500cb7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8fd7c518b62990c62de5f8fcbad24606
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d68d6050abe8e9c466e47b1023f6805f
date 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.bjc.6603391
https://pubmed.ncbi.nlm.nih.gov/PMC2360567
https://pubmed.ncbi.nlm.nih.gov/17031403
isPartOf https://portal.issn.org/resource/ISSN/1532-1827
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial
discusses http://id.nlm.nih.gov/mesh/M0024747
http://id.nlm.nih.gov/mesh/M0024087
http://id.nlm.nih.gov/mesh/M0011157
http://id.nlm.nih.gov/mesh/M0011506
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b417e023e679477b7a58dd6b19d2a8b5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_87f11a2c599b2f3cfbbc816705b2fbee
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2bd07a19b5756264ad211f430a592075
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9c927032d4762c0a052c6e315e2c8cc5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b306bc45d73f18f20772b80ab889dacc
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e3868537116144d95299a08a96dd9ccc
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d2c6279569a5e5473d9efe0530fd802
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_79e09a32844b73c7802d9d5b7645ff63
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9a784dff46ed44d6c0b5f4ad7f906f62
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_375c17477d468e8296a40307695528e6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ef3376902b05bdf1d4f2870c2035036b
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73585e53d5ee34809e0274cb21425976
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_46e7d8a9218ab3c3b572492c82786d28

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128364298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129313279
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134385933
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60582

Total number of triples: 61.